Regional blood flow in herniparkinsonism

Positron emission tomography was used to measure global and local blood flow in 11 patients with hemiparkinsonism (before and after an acute oral dose of L-dopa) and in 26 normal subjects. Global hemispheric blood flow was not significantly different between the patients [45 ± 11 ml/(min. 100 g)] and the controls [49 ± 8 ml/(min. 100 g)]. After L-dopa, the patients' mean global hemispheric flow did not change. Measurements of local blood flow from specific, anatomically defined cortical and basal ganglia regions were performed using a newly developed stereotactic localization technique. Before L-dopa, mesocortical blood flow contralateral to the patients' symptoms was significantly less than controls (p < 0. 003), suggesting a specific abnormality in the (cortical dopaminergic projection from the ventral tegmental area. In addition, right and left pallidal blood flow were significantly less tightly coupled in patients than controls (p = 0. 0312). After L-dopa, the mesocortical blood flow remained below normal, whereas pallidal blood flow was no longer significantly different from controls (p > 0. 05).

[1]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[2]  M. Raichle,et al.  A Stereotactic Method of Anatomical Localization for Positron Emission Tomography , 1985, Journal of computer assisted tomography.

[3]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.

[4]  R Harrop,et al.  Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[5]  L. Wolfson,et al.  Cerebral blood flow and oxygen metabolism measurement with positron emission tomography in Parkinson's disease. , 1984, Monographs in neural sciences.

[6]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.

[7]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  M. Mintun,et al.  Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  P. Dupui,et al.  Cerebral Blood Flow Studied by Xenon-133 Inhalation Technique in Parkinsonism: Loss of Hyperfrontal Pattern , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  R. Roth,et al.  Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.

[11]  Y. Agid,et al.  Dopamine deficiency in the cerebral cortex in Parkinson disease , 1982, Neurology.

[12]  M. Ter-pogossian,et al.  PETT VI: A Positron Emission Tomograph Utilizing Cesium Fluoride Scintillation Detectors , 1982, Journal of computer assisted tomography.

[13]  Michel M. Ter-Pogossian,et al.  Performance Study of PETT VI, a Positron Computed Tomograph with 288 Cesium Fluoride Detectors , 1982, IEEE Transactions on Nuclear Science.

[14]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[15]  R. C. Collins,et al.  Metabolic effects of unilateral lesion of the substantia nigra , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  D. Kingsley Atlas of the Human Brain and the Orbit for Computed Tomography , 1981 .

[17]  C D Marsden,et al.  Assessment of extrapyramidal disorders. , 1981, British journal of clinical pharmacology.

[18]  Louis Sokoloff,et al.  Activity‐dependent Energy Metabolism in Rat Posterior Pituitary Primarily Reflects Sodium Pump Activity , 1980, Journal of neurochemistry.

[19]  S. Bentin,et al.  Regional cerebral blood flow in patients with Parkinson's disease. , 1979, Archives of neurology.

[20]  T. Jones,et al.  Regional impairment of cerebral oxidative metabolism in Parkinson's disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[21]  J. Murphy,et al.  Spatial organization of precentral cortex in awake primates. III. Input-output coupling. , 1978, Journal of neurophysiology.

[22]  J. Glowinski,et al.  Studies on mesocortical dopamine systems. , 1978, Advances in biochemical psychopharmacology.

[23]  M E Raichle,et al.  Correlation Between Regional Cerebral Blood Flow and Oxidative Metabolism: In Vivo Studies in Man , 1976 .

[24]  R. M. Beckstead,et al.  Convergent thalamic and mesencephalic projections to the anterior medial cortex in the rat , 1976, The Journal of comparative neurology.

[25]  R. Knill-Jones,et al.  Controlled trial of amantadine hydrochloride in Parkinson's disease. , 1970, Lancet.

[26]  Edgar M. Housepian Atlas d'anatomie stereotaxique du telencephale. , 1968 .

[27]  O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.